These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19901429)

  • 41. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.
    Rose RC; Bonnez W; Reichman RC; Garcea RL
    J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.
    Aires KA; Cianciarullo AM; Carneiro SM; Villa LL; Boccardo E; Pérez-Martinez G; Perez-Arellano I; Oliveira ML; Ho PL
    Appl Environ Microbiol; 2006 Jan; 72(1):745-52. PubMed ID: 16391114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].
    Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli.
    Hajmohammadi S; Rassi H
    Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):181-5. PubMed ID: 27244269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients.
    Achour M; Kahla S; Zeghal D; Kochbati L; Mongi M; Zouari F; Oueslati R
    Viral Immunol; 2009 Feb; 22(1):7-16. PubMed ID: 19210223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coli.
    Roos N; Breiner B; Preuss L; Lilie H; Hipp K; Herrmann H; Horn T; Biener R; Iftner T; Simon C
    Protein Expr Purif; 2020 Nov; 175():105690. PubMed ID: 32681956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
    Park MA; Kim HJ; Kim HJ
    Protein Expr Purif; 2008 May; 59(1):175-81. PubMed ID: 18343683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.
    Waheed MT; Thönes N; Müller M; Hassan SW; Razavi NM; Lössl E; Kaul HP; Lössl AG
    Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
    Baek JO; Seo JW; Kim IH; Kim CH
    Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
    Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
    Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles.
    Gupta G; Glueck R; Rishi N
    Biologicals; 2017 Mar; 46():11-22. PubMed ID: 28012703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of L1 protein from different types of HPV in Pichia pastoris using an integrative vector.
    Coimbra EC; Gomes FB; Campos JF; D'arc M; Carvalho JC; Mariz FC; Jesus AL; Stocco RC; Beçak W; Freitas AC
    Braz J Med Biol Res; 2011 Dec; 44(12):1209-14. PubMed ID: 22030867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals.
    Dauner JG; Pan Y; Hildesheim A; Kemp TJ; Porras C; Pinto LA
    Mol Cell Probes; 2012 Apr; 26(2):73-80. PubMed ID: 22285687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
    Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
    Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.
    Stanley M; Lowy DR; Frazer I
    Vaccine; 2006 Aug; 24 Suppl 3():S3/106-13. PubMed ID: 16949996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response.
    Thönes N; Herreiner A; Schädlich L; Piuko K; Müller M
    J Virol; 2008 Jun; 82(11):5472-85. PubMed ID: 18385253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.
    Rizk RZ; Christensen ND; Michael KM; Müller M; Sehr P; Waterboer T; Pawlita M
    J Gen Virol; 2008 Jan; 89(Pt 1):117-129. PubMed ID: 18089735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
    Matić S; Rinaldi R; Masenga V; Noris E
    BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.